USD
$0.00
(0.00%
)At Close (As of Nov 25, 2025)
$6.52B
Market Cap
-
P/E Ratio
-0.16
EPS
$85.84
52 Week High
$45.00
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $249M |
| Total Revenue | $1.8B |
| Cost Of Revenue | $1.6B |
| Costof Goods And Services Sold | $1.6B |
| Operating Income | $105M |
| Selling General And Administrative | - |
| Research And Development | - |
| Operating Expenses | $144M |
| Investment Income Net | - |
| Net Interest Income | -$80M |
| Interest Income | - |
| Interest Expense | $80M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $138M |
| Income Before Tax | $45M |
| Income Tax Expense | $6M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $39M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $125M |
| Ebitda | $263M |
| Net Income | $2.8M |
| Field | Value (USD) |
|---|---|
| Total Assets | $3.3B |
| Total Current Assets | $1B |
| Cash And Cash Equivalents At Carrying Value | $740M |
| Cash And Short Term Investments | $740M |
| Inventory | - |
| Current Net Receivables | $228M |
| Total Non Current Assets | $2.3B |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $81M |
| Intangible Assets Excluding Goodwill | $81M |
| Goodwill | $711M |
| Investments | - |
| Long Term Investments | $104M |
| Short Term Investments | - |
| Other Current Assets | $52M |
| Other Non Current Assets | - |
| Total Liabilities | $2.2B |
| Total Current Liabilities | $480M |
| Current Accounts Payable | $96M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $81M |
| Total Non Current Liabilities | $1.7B |
| Capital Lease Obligations | $713M |
| Long Term Debt | $992M |
| Current Long Term Debt | $25M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $1.7B |
| Other Current Liabilities | $299M |
| Other Non Current Liabilities | $3.8M |
| Total Shareholder Equity | $902M |
| Treasury Stock | - |
| Retained Earnings | -$77M |
| Common Stock | $7K |
| Common Stock Shares Outstanding | $75M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | $233M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $198M |
| Capital Expenditures | $188M |
| Change In Receivables | - |
| Change In Inventory | - |
| Profit Loss | - |
| Cashflow From Investment | -$233M |
| Cashflow From Financing | $398M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | $39M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $249M |
| Total Revenue | $1.8B |
| Cost Of Revenue | $1.6B |
| Costof Goods And Services Sold | $1.6B |
| Operating Income | $105M |
| Selling General And Administrative | - |
| Research And Development | - |
| Operating Expenses | $144M |
| Investment Income Net | - |
| Net Interest Income | -$80M |
| Interest Income | - |
| Interest Expense | $80M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $138M |
| Income Before Tax | $45M |
| Income Tax Expense | $6M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $39M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $125M |
| Ebitda | $263M |
| Net Income | $2.8M |
Sector: HEALTHCARE
Industry: DIAGNOSTICS & RESEARCH
RadNet, Inc. is a leading provider of outpatient imaging services across the United States, offering a comprehensive range of diagnostic services that include MRI, CT, PET, and X-ray procedures. Headquartered in Los Angeles, California, the company operates a vast network of imaging centers strategically positioned to deliver high-quality and accessible services to patients and referring physicians. With a strong focus on innovation and technology, RadNet is committed to enhancing patient care and optimizing workflows, thereby positioning itself as a key player in the evolving healthcare landscape.